相关实验视频

Updated: May 14, 2025

The c-FOS Protein Immunohistological Detection: A Useful Tool As a Marker of Central Pathways Involved in Specific Physiological Responses In Vivo and Ex Vivo

The c-FOS Protein Immunohistological Detection: A Useful Tool As a Marker of Central Pathways Involved in Specific Physiological Responses In Vivo and Ex Vivo

Published on: April 25, 2016

c-FOS赋予了骨髓微环境中的多发性髓瘤细胞的干细胞样特征

Naoki Osada¹, Jiro Kikuchi¹, Sae Matsuoka¹

¹Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke 329-0498, Japan.

|April 11, 2025

概括

多发性骨髓瘤 (MM) 由于复发而仍然无法治愈. 上调的c-FOS驱动了MM的耐药性和癌症干细胞特征,表明c-FOS抑制是潜在的治疗策略.

科学领域:

血液学恶性瘤是什么
癌症生物学癌症生物学
药物耐药性机制药物耐药性机制

背景情况:

多发性骨髓瘤 (MM) 是一种严重的血液性恶性瘤,预后不佳.
尽管新型药物取得了进展,但MM由于复发率高,仍然无法治愈.
骨髓微环境 (BMME) 有助于药物耐药性和最小残留疾病 (MRD),助长复发.

研究的目的:

调查AP-1转录因子c-FOS在MM药物耐药性和BMME内的癌症干细胞样性质中的作用.
探索在MM中抑制c-FOS的治疗潜力.

主要方法:

使用MM细胞和小鼠连续移植模型的体外和体内研究.
对c-FOS和IRF4表达的分析.
评估耐药性和类似癌症干细胞的特征.
评估c-FOS抑制剂T-5224.4的作用

主要成果:

升高的c-FOS表达与预后不佳相关,并在BMME内的MM细胞中赋予癌症干细胞类特征,包括耐药性.
c-FOS调节IRF4的表达,有助于这些表型.
通过T-5224抑制c-FOS,通过降低IRF4.4的调节,在连续移植试验中阻止了MM细胞再生.

结论:

c-FOS在赋予BMME内的MM细胞癌症干细胞样特征方面发挥着功能性作用.
抑制c-FOS是一种有前途的治疗策略,可以消除MRD中耐药的癌症干细胞类MM细胞,并改善患者的治疗结果.

关键词:

骨髓微环境骨髓微环境 c-FOS 的使用.癌症干细胞是一种癌症干细胞.药物耐药性耐药性药物耐药性多发性骨髓瘤是多发性骨髓瘤的一种疾病.

更多相关视频

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies

Published on: March 8, 2014

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...